Prism Johnson Board of Directors

Get the latest insights into the leadership at Prism Johnson. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Raveendra Chittoor Chairman & Ind.Director
Mr. Vijay Aggarwal Managing Director
Mr. Raakesh Jain Executive Director & CEO
Mr. Sarat Chandak Executive Director & CEO
Mr. Joseph Conrad Agnelo D'Souza Independent Director
Ms. Ravina Rajpal Independent Director
Mr. Rajan B Raheja Director
Mr. Akshay R Raheja Director

Prism Johnson Share price

PRSMJOHNSN

149.08

1.19 (-0.79%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:47 IST
BUYSELL
Today's High

155.01

Today's Low

148.30

52 Week Low

105.30

52 Week High

246.00

The current prices are delayed, login to your account for live prices

Prism Johnson FAQs

The board at Prism Johnson consists of experienced professionals, including Dr. Raveendra Chittoor , Mr. Vijay Aggarwal , and others, overseeing the company’s strategic and corporate governance.

Directors at Prism Johnson are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Raveendra Chittoor is the current chairman at Prism Johnson.

Executive directors at Prism Johnson are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Prism Johnson adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Prism Johnson, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.